Frank Hartmann
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
2008/01/17 by Michael Pfreundschuh, Joerg Schubert, Jöerg Schubert +28 · 2 citations
Medicine · #Acute Lymphoblastic Leukemia research #CAR-T cell therapy research #CHOP #Chemotherapy #Clinical endpoint #Cyclophosphamide #Gastroenterology #Internal medicine #Lymphoma #Lymphoma Diagnosis and Treatment #Medicine #Randomized controlled trial #Rituximab #Surgery #Vincristine